Italy Hormone Replacement Therapy Market Size & Outlook

The hormone replacement therapy market in Italy is expected to reach a projected revenue of US$ 1,469.2 million by 2030. A compound annual growth rate of 7.3% is expected of Italy hormone replacement therapy market from 2023 to 2030.

Revenue, 2022 (US$M)
$835.3
Forecast, 2030 (US$M)
$1,469.2
CAGR, 2023 - 2030
7.3%
Report Coverage
Italy

Italy hormone replacement therapy market, 2018-2030 (US$M)

Italy

Italy hormone replacement therapy market highlights

  • The Italy hormone replacement therapy market generated a revenue of USD 835.3 million in 2022 and is expected to reach USD 1,469.2 million by 2030.
  • The Italy market is expected to grow at a CAGR of 7.3% from 2023 to 2030.
  • In terms of segment, estrogen and progesterone replacement therapy was the largest revenue generating product in 2022.
  • Parathyroid Hormone replacement is the most lucrative product segment registering the fastest growth during the forecast period.


Hormone replacement therapy market data book summary

Market revenue in 2022USD 835.3 million
Market revenue in 2030USD 1,469.2 million
Growth rate7.3% (CAGR from 2022 to 2030)
Largest segmentEstrogen and progesterone replacement therapy
Fastest growing segmentParathyroid Hormone replacement
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationEstrogen and Progesterone Replacement Therapy, HGH replacement therapy, Thryoid hormone replacement therapy, Testosterone Replacement Therapy, Parathyroid Hormone replacement
Key market players worldwideEli Lilly and Co, Bayer AG, Hisamitsu Pharmaceutical Co Inc, Pfizer Inc, Merck & Co Inc, Viatris Inc, Novo Nordisk A/S ADR, AbbVie Inc, Roche Holding AG ADR, Ascend Wellness Holdings Inc


Other key industry trends

  • In terms of revenue, Italy accounted for 3.9% of the global hormone replacement therapy market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany hormone replacement therapy market is projected to lead the regional market in terms of revenue in 2030.
  • Spain is the fastest growing regional market in Europe and is projected to reach USD 1,198.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Hormone Replacement Therapy Market Scope

Hormone replacement therapy market segmentation & scope
Estrogen and Progesterone Replacement Therapy
HGH replacement therapy
Thryoid hormone replacement therapy
Testosterone Replacement Therapy
Parathyroid Hormone replacement
Oral
Parenteral
Transdermal
Others
Menopause
Hypothyroidism
Male hypogonadism
Growth hormone deficiency
Hypoparathyroidism

Hormone Replacement Therapy Market Companies

Name Profile # Employees HQ Website

Italy hormone replacement therapy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hormone replacement therapy market will help companies and investors design strategic landscapes.


Estrogen and progesterone replacement therapy was the largest segment with a revenue share of 53.96% in 2022. Horizon Databook has segmented the Italy hormone replacement therapy market based on estrogen and progesterone replacement therapy, hgh replacement therapy, thryoid hormone replacement therapy, testosterone replacement therapy, parathyroid hormone replacement covering the revenue growth of each sub-segment from 2018 to 2030.


Italy has around 22.8% population over the age of 65 years. It has the second-highest percentage of the oldest population in the world. Large geriatric population is highly susceptible to chronic diseases and thyroid disorders. Among females, postmenopausal issues are very commonly observed in this age group.

According to The Merck Serono Foundation, thyroid disease is a common condition in Italian inhabitants and ~10% of the population develops a thyroid disorder during their lifetime. Hypothyroidism affects ~5% of the general population. A regional population based-analysis in Italy revealed that the prevalence of hyperthyroidism is 756 per 100,000 general population and incidence is 81 per 100,000 people year.

Improving healthcare system, high investments in R&D, and favorable reimbursement policies are expected to fuel the market growth in the country. Servizio Sanitario Nazionale (SSN) provides universal coverage to Italian residents in Italy, with public health services mostly free for them. Public insurance and a small co-payment system cover treatments such as medical tests, medication, surgeries during hospitalization, physician visit, and specialist assistance.

Reasons to subscribe to Italy hormone replacement therapy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Italy hormone replacement therapy market databook

  • Our clientele includes a mix of hormone replacement therapy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Italy hormone replacement therapy market , including forecasts for subscribers. This country databook contains high-level insights into Italy hormone replacement therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Italy hormone replacement therapy market size, by product, 2018-2030 (US$M)

Italy Hormone Replacement Therapy Market Outlook Share, 2022 & 2030 (US$M)

Italy hormone replacement therapy market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more